Hepatobiliary Phase MRI as a Problem-Solving Sequence for Evaluating Potentially Metastatic Liver Lesions: A Case Series

Abstract

Background Incidentally detected focal liver lesions in patients with known primary malignancy often pose a diagnostic challenge and are labeled as indeterminate. Utilizing an additional hepatobiliary phase as an adjunct in these cases helps to differentiate potentially metastatic lesions from benign or pseudo lesions.

Aim We share three cases where hepatobiliary phase imaging for an indeterminate hepatic observation helped in differentiating benign from metastatic etiology. We also briefly discuss the different appearances of liver lesions in post-chemotherapy patients.

Results and Conclusion Out of the three cases, one had a hypointense appearance on the hepatobiliary phase suggesting metastasis, while the other two had iso- or hyperintense appearance suggesting a benign or pseudo lesion.

Keywords

gadobenate dimeglumine - hepatobiliary phase - magnetic resonance imaging - metastasis

Publication History

Article published online:
01 April 2025

• References

• 1 Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 2009; 29 (06) 1725-1748
• 2 Francisco FAF, de Araújo ALE, Oliveira Neto JA, Parente DB. Hepatobiliary contrast agents: differential diagnosis of focal hepatic lesions, pitfalls and other indications. Radiol Bras 2014; 47 (05) 301-309
• 3 Pirovano G, Vazulli A, Marti-Bonmati L. et al. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. Appl Radiol 2003; 32: 147-159
• 4 Caudana R, Morana G, Pirovano GP. et al. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)–preliminary results of phase II clinical application. Radiology 1996; 199 (02) 513-520
• 5 Spinazzi A, Lorusso V, Pirovano G, Taroni P, Kirchin M, Davies A. Multihance clinical pharmacology: biodistribution and MR enhancement of the liver. Acad Radiol 1998; 5 (Suppl. 01) S86-S89 , discussion S93–S94
• 6 Morana G, Grazioli L, Kirchin MA. et al. Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration. Invest Radiol 2011; 46 (04) 225-239
• 7 Choi JY, Choi JS, Kim MJ. et al. Detection of hepatic hypovascular metastases: 3D gradient echo MRI using a hepatobiliary contrast agent. J Magn Reson Imaging 2010; 31 (03) 571-578
• 8 Kim YK, Lee JM, Kim CS, Chung GH, Kim CY, Kim IH. Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 2005; 15 (02) 220-228
• 9 Kim A, Lee CH, Kim BH. et al. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a “defect” on the hepatobiliary phase. Eur J Radiol 2012; 81 (12) 3998-4004
• 10 Conti JA, Kendall TJ, Bateman A. et al. The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation. Clin Cancer Res 2008; 14 (20) 6405-6413
• 11 Kim YK, Lee JM, Kim CS. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 2004; 14 (01) 5-13
• 12 Granata V, Catalano O, Fusco R. et al. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA “uptake” on the hepatobiliary phase of MR imaging. Abdom Imaging 2015; 40 (07) 2364-2371
• 13 Pozowski P, Misiak P, Szymańska K. et al. Atypical enhancement of gd-bopta on the hepatobiliary phase in hepatic metastasis from carcinoid tumor – case report. Am J Case Rep 2020; 21: e924280